Related Experiment Video

Updated: May 24, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a

E Marc Jolicoeur1, Raymond Cartier, Tim D Henry

  • 1Montreal Heart Institute, Université de Montréal, Montréal, Québec, Canada. marc.jolicoeur@icm-mhi.org

The Canadian Journal of Cardiology
|March 20, 2012
PubMed

Insights

This report introduces a new angiographic classification for coronary artery disease (CAD) patients unsuitable for revascularization. The proposed system aims to standardize data collection and guide clinical trials for refractory angina (RFA).

Area of Science:

  • Cardiology
  • Medical Classification Systems

Background:

  • Coronary artery disease (CAD) presents challenges in patients unsuitable for revascularization.
  • Refractory angina (RFA) and advanced CAD require standardized management and research approaches.

Purpose of the Study:

  • To propose a simple, angiographic-based classification for CAD patients unsuitable for revascularization.
  • To aid in standardizing epidemiological data collection for RFA and advanced CAD.
  • To facilitate the development of clinical trials for innovative therapies in RFA.

Main Methods:

  • Review of phenotypes of CAD patients unsuitable for revascularization.
  • Analysis of these phenotypes to develop a classification system.
  • Proposal of four distinct angiographic phenotypes: suspected cardiac syndrome X, limited territory at risk, diffuse thread-like coronary atherosclerosis, and end-stage CAD.

Main Results:

  • A novel four-phenotype classification system for CAD patients unsuitable for revascularization is presented.
  • The classification is based on angiographic findings.
  • The proposed phenotypes are: suspected cardiac syndrome X, limited territory at risk, diffuse thread-like coronary atherosclerosis, and end-stage CAD.

Conclusions:

  • The proposed classification aims to standardize data collection and clinical trial development for RFA.
  • This system is the first of its kind and intended to stimulate discussion and improve management of this patient group.
  • Standardization is crucial for advancing the treatment of challenging CAD cases.

More Related Videos

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...